A. Janusz

High MMP‐9 activity levels in fragile X syndrome are lowered by minocycline

Dalyir I. Pretto, L. Kaczmarek, F. Tassone, 2013, American journal of medical genetics. Part A.

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer

A. Janusz, Marta Smycz-Kubanska, A. Mielczarek-Palacz, 2022, Molecular medicine reports.

Spontaneously immortalized T lymphocytes from Nijmegen Breakage Syndrome patients display phenotypes typical for lymphoma cells.

R. Płoski, K. Chrzanowska, P. Kuźniar, 2008, Leukemia research.

Transfusion-associated mast cell activation syndrome (TA-MCAS) with course including EAR phase or EAR and LAR phases – hypothesis of a new complication upon transfusion of blood components

J. Skowrońska, K. Wieczorek, Anna Grajewska, 2015 .

The Role of Selected Chemokines in the Peritoneal Fluid of Women with Endometriosis—Participation in the Pathogenesis of the Disease

A. Janusz, J. Sikora, Marta Smycz-Kubanska, 2021, Processes.

Activity-Dependent Local Translation of Matrix Metalloproteinase-9

L. Kaczmarek, C. Bramham, A. Tiron, 2012, The Journal of Neuroscience.

The Fragile X Mental Retardation Protein Regulates Matrix Metalloproteinase 9 mRNA at Synapses

L. Kaczmarek, L. Pacini, C. Bagni, 2013, The Journal of Neuroscience.

Participation of Selected Soluble BMP-2 and BMP-7 Bone Morphogenetic Proteins and Their Soluble Type I ALK-1 and Type II BMPR2 Receptors in Formation and Development of Endometriosis

A. Janusz, J. Sikora, Marta Smycz-Kubanska, 2021, Biomedicines.

Participation of selected soluble cell adhesion molecules and syndecans in formation and development of endometriosis.

A. Janusz, J. Sikora, Marta Smycz-Kubanska, 2021, Ginekologia polska.